MiMedx Group, Inc. (MDXG)
NASDAQ$8.09
Market Cap
$1.19B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
705 of 924
Rank in Industry
402 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
MDXG Insider Trading Activity
MDXG Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $1,624,738 | 5 | 100 |
Related Transactions
| Maersk-Moller Kimberly | Chief Commercial Officer | 0 | $0 | 2 | $50,139 | $-50,139 |
| Whitlow Ricci S | Chief Operating Officer | 0 | $0 | 1 | $508,558 | $-508,558 |
| Hulse William Frank IV | General Counsel and CAO | 0 | $0 | 2 | $1.07M | $-1.07M |
About MiMedx Group, Inc.
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of …
Insider Activity of MiMedx Group, Inc.
Over the last 12 months, insiders at MiMedx Group, Inc. have bought $0 and sold $1.62M worth of MiMedx Group, Inc. stock.
On average, over the past 5 years, insiders at MiMedx Group, Inc. have bought $676,221 and sold $1.24M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,000 shares for transaction amount of $35,787 was made by DOUG RICE (Chief Financial Officer) on 2023‑11‑21.
List of Insider Buy and Sell Transactions, MiMedx Group, Inc.
| 2025-03-13 | Sale | Hulse William Frank IV | General Counsel and CAO | 54,596 0.037% | $7.89 | $430,762 | +1.27% | |
| 2025-03-13 | Sale | Maersk-Moller Kimberly | Chief Commercial Officer | 4,106 0.0028% | $7.89 | $32,396 | +1.27% | |
| 2025-03-10 | Sale | Hulse William Frank IV | General Counsel and CAO | 81,446 0.0553% | $7.80 | $635,279 | +3.21% | |
| 2025-02-28 | Sale | Maersk-Moller Kimberly | Chief Commercial Officer | 2,111 0.0015% | $8.40 | $17,743 | -4.34% | |
| 2025-02-13 | Sale | Whitlow Ricci S | Chief Operating Officer | 61,420 0.0422% | $8.28 | $508,558 | -2.90% | |
| 2024-03-13 | Sale | Hulse William Frank IV | General Counsel and CAO | 20,381 0.0139% | $7.95 | $162,029 | -8.30% | |
| 2024-02-20 | Sale | Whitlow Ricci S | Chief Operating Officer | 15,271 0.0131% | $8.01 | $122,351 | -9.33% | |
| 2024-02-16 | Sale | Whitlow Ricci S | Chief Operating Officer | 15,493 0.0133% | $8.07 | $125,075 | -9.55% | |
| 2024-02-15 | Sale | Whitlow Ricci S | Chief Operating Officer | 15,198 0.013% | $8.06 | $122,496 | -11.53% | |
| 2024-02-14 | Sale | Whitlow Ricci S | Chief Operating Officer | 15,845 0.0132% | $8.03 | $127,267 | -9.67% | |
| 2023-11-21 | DOUG RICE | Chief Financial Officer | 5,000 0.0043% | $7.16 | $35,787 | +1.25% | ||
| 2023-06-23 | Capper Joseph H | Chief Executive Officer | 42,025 0.037% | $6.50 | $273,331 | +17.52% | ||
| 2023-06-22 | Capper Joseph H | Chief Executive Officer | 57,975 0.0504% | $6.33 | $367,104 | +19.00% | ||
| 2023-05-16 | Sale | Stein Robert Benjamin | President, Regenerative Med. | 10,365 0.009% | $5.95 | $61,627 | +25.71% | |
| 2023-05-15 | Sale | Stein Robert Benjamin | President, Regenerative Med. | 3,607 0.0032% | $6.15 | $22,170 | +23.93% | |
| 2023-05-10 | Sale | Carlson Peter M | Chief Financial Officer | 5,976 0.0051% | $5.93 | $35,414 | +23.68% | |
| 2023-05-10 | Sale | Hulse William Frank IV | General Counsel and CAO | 5,870 0.005% | $5.93 | $34,786 | +23.68% | |
| 2023-05-10 | Sale | Stein Robert Benjamin | President, Regenerative Med. | 5,869 0.005% | $5.93 | $34,780 | +23.68% | |
| 2023-05-10 | Sale | Phelan William Lawrence | Chief Accounting Officer | 1,595 0.0014% | $5.93 | $9,452 | +23.68% | |
| 2023-05-04 | Sale | Stein Robert Benjamin | President, Regenerative Med. | 51,756 0.0437% | $5.34 | $276,470 | +35.62% |
Total: 156
*Gray background shows transactions not older than one year
Insider Historical Profitability
34.68%
| PETIT PARKER H | Chairman & CEO | 5009121 3.3991% | $40.52M | 9 | 1 | +25.79% |
| KOOB CHARLES E | director | 1312306 0.8905% | $10.62M | 3 | 1 | +51.39% |
| Eichler Kurt M | director | 574576 0.3899% | $4.65M | 2 | 0 | |
| Taylor William Charles | President and COO | 467424 0.3172% | $3.78M | 1 | 19 | +61.76% |
| GORLIN STEVE | director | 451857 0.3066% | $3.66M | 29 | 9 | +51.19% |
Historical Insider Profitability vs. Competitors
$8,217,280 | 112 | 46.33% | $1.27B | |
$54,590,806 | 65 | 21.84% | $1.22B | |
$1,101,324,300 | 58 | 37.37% | $1.28B | |
$571,084,134 | 44 | 4.33% | $962.09M | |
$100,002,191 | 42 | 21.48% | $1.26B |
MDXG Institutional Investors: Active Positions
| Increased Positions | 100 | +43.29% | 8M | +8.3% |
| Decreased Positions | 90 | -38.96% | 5M | -5.26% |
| New Positions | 47 | New | 5M | New |
| Sold Out Positions | 23 | Sold Out | 533,088 | Sold Out |
| Total Postitions | 241 | +4.33% | 101M | +3.04% |
MDXG Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Essex Woodlands Management, Inc. | $223,306.00 | 19.18% | 28.2M | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $76,004.00 | 6.53% | 9.6M | -10,437 | -0.11% | 2024-12-31 |
| Trigran Investments, Inc. | $60,362.00 | 5.19% | 7.62M | -68,852 | -0.9% | 2024-12-31 |
| Vanguard Group Inc | $53,109.00 | 4.56% | 6.71M | -262,667 | -3.77% | 2024-12-31 |
| Paradigm Capital Management Inc/Ny | $37,115.00 | 3.19% | 4.69M | +22,131 | +0.47% | 2024-12-31 |
| Cannell Capital Llc | $28,825.00 | 2.48% | 3.64M | +40,235 | +1.12% | 2024-12-31 |
| First Light Asset Management, Llc | $26,483.00 | 2.28% | 3.34M | +3M | New | 2024-12-31 |
| State Street Corp | $25,904.00 | 2.23% | 3.27M | -589,418 | -15.27% | 2024-12-31 |
| Geode Capital Management, Llc | $22,013.00 | 1.89% | 2.78M | -14,949 | -0.54% | 2024-12-31 |
| Renaissance Technologies Llc | $14,292.00 | 1.23% | 1.8M | +280,327 | +18.39% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.